Buy Now
Ablation Devices Market Size, Share, Growth & Industry Analysis, By Technology (Radiofrequency devices, Laser/light ablation, Ultrasound devices, Cryoablation devices, Others), By Application (Cardiology, Oncology, Ophthalmology, Gynecology), By End Use (Hospitals, Ambulatory surgical centers), and Regional Analysis, 2024-2031
Pages: 170 | Base Year: 2023 | Release: April 2025 | Author: Versha V.
The market includes the global ecosystem of technologies and applications that use energy-based devices to remove or destroy targeted tissues. It covers a wide range of solutions used across multiple medical specialties such as cardiology, oncology, ophthalmology, gynecology, urology, and cosmetic surgery.
Key modalities include radiofrequency, laser/light, ultrasound, cryoablation, and emerging technologies. The report examines critical driving factors, industry trends, regional developments, and regulatory frameworks impacting market growth through the projection period.
The global ablation devices market size was valued at USD 7.43 billion in 2023 and is projected to grow from USD 8.07 billion in 2024 to USD 15.38 billion by 2031, exhibiting a CAGR of 9.66% during the forecast period.
This growth is fueled by the rising prevalence of chronic diseases such as cardiovascular conditions, cancer, and arrhythmias. The growing aging population is boosting demand for effective treatment options such as ablation procedures. Technological advancements, including improved precision, real-time monitoring, and enhanced safety features, are further contributing to market growth.
Major companies operating in the ablation devices industry are Imricor, Terumo Corporation, Merit Medical Systems, Smith+Nephew, Koninklijke Philips N.V., Medtronic, AngioDynamics, Johnson & Johnson Services, Inc., Lumenis Be Ltd., Biotronik, EDAP TMS SA, Boston Scientific Corporation, Stryker, Atricure, Inc., and Abbott.
Additionally, minimally invasive procedures are becoming increasingly preferred by both healthcare providers and patients due to the faster recovery times and reduced risk of complications. These procedures offer benefits such as smaller incisions, less tissue damage, and shorter hospital stays.
Market Driver
Rising Prevalence of Chronic Diseases
The expansion of the global market is propelled by the rising prevalence of chronic diseases. As conditions such as cancer, cardiovascular diseases, and arrhythmias become more widespread, there is a growing demand for effective treatment options.
Ablation devices provide a minimally invasive solution for managing these diseases, offering benefits such as faster recovery times and lower complication risks compared to traditional surgeries. This has led to an increased adoption of ablation procedures, particularly for treating cardiac arrhythmias such as atrial fibrillation. The rising burden of chronic diseases across the globe is leading to the growing demand for ablation devices.
Market Challenge
High Cost of Devices and Procedures
A major challenge hampering the progress of the ablation devices market is the high cost of both the devices and associated procedures. The significant investment required for advanced technology makes these systems expensive for healthcare facilities, particularly in emerging markets. This cost barrier limits accessibility and adoption, particularly in budget-constrained regions.
To address this challenge, companies can focus on developing cost-effective ablation devices by optimizing manufacturing processes, reducing material costs, and adopting innovative technologies that maintain quality and safety. Additionally, offering flexible pricing models and partnerships with healthcare providers could also help make these devices more accessible to a broader range of facilities and patients.
Market Trend
Minimally Invasive Procedures
The global market is witnessing a significant shift toward minimally invasive procedures. This shift is supported by the numerous advantages these procedures offer, including faster recovery times, reduced risk of complications, and lower overall healthcare costs.
Techniques such as radiofrequency and cryoablation, which involve smaller incisions and less tissue damage, lead to shorter hospital stays and quicker recovery. Consequently, healthcare providers and patients are increasingly opting for these treatments over traditional surgeries, particularly for treating chronic conditions such as atrial fibrillation and cancer.
Segmentation |
Details |
By Technology |
Radiofrequency devices, Laser/light ablation, Ultrasound devices, Cryoablation devices, Others |
By Application |
Cardiology, Oncology, Ophthalmology, Gynecology, Urology, Cosmetic surgery, Others |
By End Use |
Hospitals, Ambulatory surgical centers |
By Region |
North America: U.S., Canada, Mexico |
Europe: France, UK, Spain, Germany, Italy, Russia, Rest of Europe |
|
Asia-Pacific: China, Japan, India, Australia, ASEAN, South Korea, Rest of Asia-Pacific |
|
Middle East & Africa: Turkey, UAE, Saudi Arabia, South Africa, Rest of Middle East & Africa |
|
South America: Brazil, Argentina, Rest of South America |
Market Segmentation:
Based on region, the global market has been classified into North America, Europe, Asia Pacific, Middle East & Africa, and South America.
North America ablation devices market share stood at around 33.24% in 2023, valued at USD 2.47 billion. This dominance is reinforced by strong healthcare infrastructure and early adoption of advanced medical technologies. High prevalence of cardiac disorders and cancer has increased the demand for ablation procedures.
Favorable reimbursement policies and increased healthcare spending have further supported regional market expansion. FDA approvals for novel ablation devices have accelerated clinical adoption, while the presence of key market players and continuous product innovation have reinforced the region’s dominance.
Asia Pacific ablation devices industry is poised to grow at a CAGR of 10.68% over the forecast period. This growth is fueled by a rising patient population and increasing awareness about minimally invasive treatments. Government initiatives to strengthen healthcare systems and improve access to modern procedures are contributing significantly to this expansion.
Rapid urbanization, growing medical tourism, and the expansion of private hospitals have created new growth opportunities. Countries such as China, India, and South Korea are witnessing a surge in demand for ablation devices due to higher investments in healthcare infrastructure.
The ablation devices market is highly competitive, with key players employing a variety of strategies to strengthen their market positions and expand their market share. A significant strategy used by leading companies is product innovation. Many companies are focused on developing advanced, minimally invasive ablation devices that offer improved precision, reduced recovery times, and better patient outcomes.
Strategic partnerships and collaborations are also a key focus. Companies frequently collaborate with healthcare providers, research institutions, and technology firms to enhance product development, expand clinical applications, and improve distribution networks. These partnerships allow companies to access new technologies, gain insights into emerging treatment methods, and tap into new geographic markets.
Recent Developments (Approval)